Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

Mingzhi Zhang · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
nk/t cell lymphoma, pd-1 antibody, chidamide, lenalidomide, etoposide, nk/t-cell lymphoma, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889476
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.